USD 2.03
(-6.45%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 58.58 Million USD | -13.83% |
2022 | 67.98 Million USD | 3.66% |
2021 | 65.58 Million USD | 13.43% |
2020 | 57.82 Million USD | -7.47% |
2019 | 62.48 Million USD | 0.46% |
2018 | 62.19 Million USD | 30.4% |
2017 | 47.69 Million USD | -3.74% |
2016 | 49.55 Million USD | -0.2% |
2015 | 49.64 Million USD | 16.79% |
2014 | 42.5 Million USD | -3.41% |
2013 | 44 Million USD | -10.08% |
2012 | 48.94 Million USD | 11.95% |
2011 | 43.71 Million USD | 6.47% |
2010 | 41.06 Million USD | 24.01% |
2009 | 33.11 Million USD | 3.09% |
2008 | 32.11 Million USD | 4.57% |
2007 | 30.71 Million USD | 4.48% |
2006 | 29.39 Million USD | 15.96% |
2005 | 25.35 Million USD | -39.2% |
2004 | 41.69 Million USD | 16.64% |
2003 | 35.74 Million USD | 45.42% |
2002 | 24.58 Million USD | 26.43% |
2001 | 19.44 Million USD | -24.65% |
2000 | 25.8 Million USD | 109.38% |
1999 | 12.32 Million USD | 180.64% |
1998 | 4.39 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 14.75 Million USD | 0.66% |
2024 Q2 | 13.7 Million USD | -7.08% |
2023 Q3 | 15.66 Million USD | -1.37% |
2023 FY | 58.58 Million USD | -13.83% |
2023 Q1 | 16.59 Million USD | 1.88% |
2023 Q4 | 14.65 Million USD | -6.41% |
2023 Q2 | 15.87 Million USD | -4.34% |
2022 Q4 | 16.29 Million USD | -1.14% |
2022 FY | 67.98 Million USD | 3.66% |
2022 Q3 | 16.47 Million USD | -5.94% |
2022 Q2 | 17.51 Million USD | -1.01% |
2022 Q1 | 17.69 Million USD | -0.91% |
2021 Q4 | 17.86 Million USD | 13.33% |
2021 Q1 | 15.67 Million USD | 4.8% |
2021 Q3 | 15.76 Million USD | -3.28% |
2021 Q2 | 16.29 Million USD | 3.99% |
2021 FY | 65.58 Million USD | 13.43% |
2020 Q3 | 13.31 Million USD | 0.1% |
2020 Q4 | 14.95 Million USD | 12.31% |
2020 FY | 57.82 Million USD | -7.47% |
2020 Q1 | 16.25 Million USD | -73.99% |
2020 Q2 | 13.3 Million USD | -18.18% |
2019 FY | 62.48 Million USD | 0.46% |
2019 Q3 | 15.88 Million USD | 7.43% |
2019 Q4 | 62.48 Million USD | 293.38% |
2019 Q2 | 14.78 Million USD | -8.28% |
2019 Q1 | 16.12 Million USD | -5.17% |
2018 FY | 62.19 Million USD | 30.4% |
2018 Q1 | 14.53 Million USD | 16.29% |
2018 Q3 | 14.92 Million USD | -5.15% |
2018 Q4 | 16.99 Million USD | 13.87% |
2018 Q2 | 15.73 Million USD | 8.27% |
2017 Q1 | 12.13 Million USD | 0.84% |
2017 FY | 47.69 Million USD | -3.74% |
2017 Q4 | 12.49 Million USD | 6.15% |
2017 Q3 | 11.77 Million USD | 4.33% |
2017 Q2 | 11.28 Million USD | -7.02% |
2016 Q3 | 11.84 Million USD | -5.35% |
2016 Q4 | 12.03 Million USD | 1.63% |
2016 Q1 | 13.15 Million USD | 5.16% |
2016 FY | 49.55 Million USD | -0.2% |
2016 Q2 | 12.51 Million USD | -4.87% |
2015 Q1 | 12.57 Million USD | 6.47% |
2015 Q3 | 12.12 Million USD | -2.55% |
2015 Q4 | 12.51 Million USD | 3.18% |
2015 FY | 49.64 Million USD | 16.79% |
2015 Q2 | 12.44 Million USD | -1.03% |
2014 Q1 | 10.29 Million USD | 60.48% |
2014 Q2 | 10.42 Million USD | 1.31% |
2014 FY | 42.5 Million USD | -3.41% |
2014 Q4 | 11.8 Million USD | 19.02% |
2014 Q3 | 9.92 Million USD | -4.84% |
2013 FY | 44 Million USD | -10.08% |
2013 Q4 | 6.41 Million USD | -47.71% |
2013 Q3 | 12.26 Million USD | -4.88% |
2013 Q2 | 12.89 Million USD | 3.58% |
2013 Q1 | 12.44 Million USD | -0.81% |
2012 Q3 | 12.04 Million USD | -2.31% |
2012 Q4 | 12.54 Million USD | 4.18% |
2012 Q1 | 12.02 Million USD | 1.69% |
2012 FY | 48.94 Million USD | 11.95% |
2012 Q2 | 12.32 Million USD | 2.56% |
2011 Q3 | 11.18 Million USD | 8.62% |
2011 Q2 | 10.29 Million USD | -1.2% |
2011 Q1 | 10.41 Million USD | -7.26% |
2011 FY | 43.71 Million USD | 6.47% |
2011 Q4 | 11.82 Million USD | 5.72% |
2010 Q2 | 9.67 Million USD | -1.31% |
2010 Q4 | 11.23 Million USD | 8.65% |
2010 FY | 41.06 Million USD | 24.01% |
2010 Q3 | 10.34 Million USD | 6.85% |
2010 Q1 | 9.8 Million USD | -3.15% |
2009 Q2 | 7.71 Million USD | 9.71% |
2009 Q1 | 7.03 Million USD | -12.87% |
2009 FY | 33.11 Million USD | 3.09% |
2009 Q4 | 10.12 Million USD | 22.88% |
2009 Q3 | 8.24 Million USD | 6.8% |
2008 Q1 | 8.18 Million USD | -7.51% |
2008 Q4 | 8.07 Million USD | 7.37% |
2008 FY | 32.11 Million USD | 4.57% |
2008 Q3 | 7.51 Million USD | -9.93% |
2008 Q2 | 8.34 Million USD | 1.98% |
2007 Q2 | 7.42 Million USD | 3.77% |
2007 Q1 | 7.15 Million USD | -13.8% |
2007 Q3 | 7.27 Million USD | -2.06% |
2007 FY | 30.71 Million USD | 4.48% |
2007 Q4 | 8.84 Million USD | 21.62% |
2006 Q4 | 8.3 Million USD | 10.72% |
2006 Q2 | 6.95 Million USD | 4.71% |
2006 Q1 | 6.63 Million USD | 0.38% |
2006 FY | 29.39 Million USD | 15.96% |
2006 Q3 | 7.5 Million USD | 7.9% |
2005 Q1 | 10.54 Million USD | -3.15% |
2005 Q2 | 29.07 Million USD | 175.85% |
2005 Q3 | 6.12 Million USD | -78.95% |
2005 Q4 | 6.61 Million USD | 8.05% |
2005 FY | 25.35 Million USD | -39.2% |
2004 Q3 | 9.72 Million USD | -9.05% |
2004 Q4 | 10.88 Million USD | 11.93% |
2004 Q2 | 10.69 Million USD | 2.22% |
2004 Q1 | 10.45 Million USD | 15.11% |
2004 FY | 41.69 Million USD | 16.64% |
2003 FY | 35.74 Million USD | 45.42% |
2003 Q2 | 9.29 Million USD | 7.91% |
2003 Q3 | 8.74 Million USD | -5.96% |
2003 Q4 | 9.08 Million USD | 3.89% |
2003 Q1 | 8.61 Million USD | -0.07% |
2002 Q2 | 5.58 Million USD | 11.01% |
2002 Q3 | 5.33 Million USD | -4.51% |
2002 Q1 | 5.03 Million USD | -9.98% |
2002 FY | 24.58 Million USD | 26.43% |
2002 Q4 | 8.62 Million USD | 61.64% |
2001 Q2 | 4.71 Million USD | 29.45% |
2001 Q3 | 5.4 Million USD | 14.53% |
2001 FY | 19.44 Million USD | -24.65% |
2001 Q1 | 3.64 Million USD | 108.91% |
2001 Q4 | 5.59 Million USD | 3.52% |
2000 FY | 25.8 Million USD | 109.38% |
2000 Q1 | - USD | 0.0% |
2000 Q4 | -40.9 Million USD | 0.0% |
2000 Q3 | - USD | 0.0% |
2000 Q2 | - USD | 0.0% |
1999 FY | 12.32 Million USD | 180.64% |
1998 FY | 4.39 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Akoya Biosciences, Inc. | 104.27 Million USD | 43.818% |
AngioDynamics, Inc. | 252.41 Million USD | 76.792% |
AtriCure, Inc. | 327.05 Million USD | 82.088% |
Avinger, Inc. | 18.63 Million USD | -214.309% |
Azenta, Inc. | 336.26 Million USD | 82.579% |
BioLife Solutions, Inc. | 117.57 Million USD | 50.176% |
The Cooper Companies, Inc. | 1.82 Billion USD | 96.79% |
Daxor Corporation | 1.28 Million USD | -4474.8% |
Ekso Bionics Holdings, Inc. | 24.19 Million USD | -142.16% |
Femasys Inc. | 15.2 Million USD | -285.393% |
GlucoTrack, Inc. | 7.1 Million USD | -724.62% |
Hologic, Inc. | 1.34 Billion USD | 95.645% |
ICU Medical, Inc. | 717.04 Million USD | 91.83% |
Intuitive Surgical, Inc. | 2.96 Billion USD | 98.023% |
KORU Medical Systems, Inc. | 26.1 Million USD | -124.381% |
LeMaitre Vascular, Inc. | 90.33 Million USD | 35.153% |
Innovative Eyewear, Inc. | -119.32 Thousand USD | 49192.006% |
Innovative Eyewear, Inc. | -119.32 Thousand USD | 49192.006% |
Masimo Corporation | 867 Million USD | 93.243% |
Microbot Medical Inc. | 9.85 Million USD | -494.429% |
Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | -218.028% |
Merit Medical Systems, Inc. | 459.92 Million USD | 87.263% |
Nephros, Inc. | 9.78 Million USD | -498.743% |
NovoCure Limited | 613.92 Million USD | 90.458% |
NEXGEL, Inc. | 4.09 Million USD | -1330.2% |
NEXGEL, Inc. | 4.09 Million USD | -1330.2% |
Singular Genomics Systems, Inc. | 102.24 Million USD | 42.704% |
OraSure Technologies, Inc. | 125.34 Million USD | 53.263% |
Pro-Dex, Inc. | 7.37 Million USD | -693.996% |
Pulse Biosciences, Inc. | 43.57 Million USD | -34.44% |
Predictive Oncology Inc. | 15.22 Million USD | -284.654% |
Precision Optics Corporation, Inc. | 8.52 Million USD | -587.4% |
QuidelOrtho Corporation | 1.35 Billion USD | 95.678% |
Repligen Corporation | 261.12 Million USD | 77.566% |
Sanara MedTech Inc. | 61.12 Million USD | 4.165% |
STAAR Surgical Company | 224.55 Million USD | 73.912% |
Sharps Technology, Inc. | 10.12 Million USD | -478.484% |
Utah Medical Products, Inc. | 13.26 Million USD | -341.754% |
DENTSPLY SIRONA Inc. | 1.79 Billion USD | 96.735% |
Jin Medical International Ltd. | 3.91 Million USD | -1395.339% |